Cart
sales@molnova.com
(S)-(+)-N-3-Benzylnirvanol
CAS No. 790676-40-3
(S)-(+)-N-3-Benzylnirvanol( —— )
Catalog No. M36083 CAS No. 790676-40-3
(S)-(+)-N-3-Benzylnirvanol is a cytochrome P450 CYP2C19 inhibitor with a ki value of 82.5μM for CYP2C9 and 0.25μM for CYP2C19, which can be used to study HIV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 359 | In Stock |
|
| 10MG | 531 | In Stock |
|
| 25MG | 839 | In Stock |
|
| 50MG | 1107 | In Stock |
|
| 100MG | 1469 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(S)-(+)-N-3-Benzylnirvanol
-
NoteResearch use only, not for human use.
-
Brief Description(S)-(+)-N-3-Benzylnirvanol is a cytochrome P450 CYP2C19 inhibitor with a ki value of 82.5μM for CYP2C9 and 0.25μM for CYP2C19, which can be used to study HIV infection.
-
Description(S)-(+)-N-3-Benzylnirvanol is a drug used formetabolic regulation. (S)-(+)-N-3-Benzylnirvanol has the activity of inhibitinghuman P450 enzyme. (S)-(+) -n-3-benzylnirvanol can be used to study druginteractions during drug metabolism .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease | P450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number790676-40-3
-
Formula Weight294.35
-
Molecular FormulaC18H18N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (339.73 mM; Ultrasonic )
-
SMILESC(C)[C@@]1(C(=O)N(CC2=CC=CC=C2)C(=O)N1)C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. KimMJ, et al. High-throughput screening of inhibitory potential of nine cytochromeP450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.Rapid Commun Mass Spectrom. 2005;19(18):2651-8.?
molnova catalog
related products
-
NSC260594
NSC260594 (NSC 260594) is a specific inhibitor of HIV-1 RNA packaging.
-
GS-9695
GS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM.
-
(±)-BI-D
A potent, allosteric HIV integrase inhibitor (Kd=34 nM) that binds the LEDGF/p75 binding site on integrase.
